Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Graham Beastall Elected New IFCC President

By LabMedica International staff writers
Posted on 05 Oct 2008
Graham Beastall of the UK was elected President for the 2009-11 term by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) at the organization's 20th Triennial IFCC Council meeting, which took place during the IFCC-WorldLab Congress held in Fortaleza, Brazil, from Sept. More...
28 to Oct. 2, 2008.

Dr. Beastall will be taking over from Jocelyn Hicks of the US, who is serving as IFCC President for the current three-year term. Other candidates in the election were Victor Blaton, Belgium, and Jean-Claude Forest, Canada.

Also elected with Dr. Beastall for the same three-year term were six incoming members of the IFCC Executive Board: Chris W Lam, Hong Kong (Vice President); Paivi Laitinen, Finland (Secretary); Ghassan Shannan, Syria (Treasurer); Bernard Gouget, France (Member); Joseph Lopes, Malaysia (Member); Ulisses Tuma, Brazil (Member).

Graham Beastall, BSc, PhD, CSci, EurClinChem, FRCPath, FRCP(Glas), has served as Consultant Clinical Scientist and Clinical Lead for the four-site Department of Clinical Biochemistry in the North Glasgow division of UK's National Health Service (NHS) for the past five years. Dr. Beastall served as President of the [UK] Association for Clinical Biochemistry (ACB) for 2006-2009 and Vice President of the [UK] Royal College of Pathologists (RCPath) for 2002-2005. He has held senior positions with the IFCC and EFCC (European Federation of Clinical Chemistry and Laboratory Medicine) and authored over 170 scientific articles and reviews. As an adviser to the UK government, Dr. Beastall has worked closely with the Chief Scientific Officer in the [UK] Department of Health. Dr. Beastall's research interests are in the areas of biochemical endocrinology, evidence-based medicine, and service modernization.

IFCC is the world's leading clinical laboratory umbrella organization, incorporating 79 national societies, five regional federations, and 36 industry members.

Related Links:

IFCC

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Automatic CLIA Analyzer
Shine i6000
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.